Switzerland: 5,000 participants recruited to establish a trial on recreational cannabis

Newsweed reports

It is a life-size test, to observe the advantages and disadvantages of legalizing recreational cannabis. From May 15, and for a maximum of seven years, 5,000 Swiss over the age of 18 will be able to legally smoke cannabis. They will have to respect a few conditions: be already consumers, accept a follow-up and limit their consumption.

“These studies will make it possible in particular to evaluate and document, in a scientific framework, its effects on the health of users and on consumption habits. But also to measure its impact on the local illicit drug market as well as on the protection of young people and on public security ” , indicates the Federal Council, the Swiss government, in its press release .

Concretely, the 5,000 Swiss who applied will be able to buy cannabis with a maximum of 20% THC, i.e. 5% above the average . It “must meet high quality requirements and be organically grown”. Each month, they will be able to consume a maximum of 10 grams of pure THC, i.e. 50 grams of flowers at 20% THC. These guinea pigs will agree not to smoke in the public space. Finally, they will be made aware of the risks associated with consumption “by the staff of the points of sale who will be trained accordingly” .

More info at

Suisse : 5000 participants pour un essai sur le cannabis récréatif

 

 THE FEDERAL COUNCIL PRESS RELEASE

Pilot trials on controlled cannabis delivery may begin in May

Bern, 03.31.2021 – At its meeting on March 31, 2021, the Federal Council adopted the ordinance on pilot tests for the controlled release of cannabis for non-medical purposes. The text specifies the strict conditions under which the studies may be carried out. The aim of these trials is to provide a solid scientific basis for future decisions on the regulation of cannabis.

As of May 15, 2021, requests for the setting up of pilot trials on the consumption of cannabis for non-medical purposes can be submitted to the Federal Office of Public Health. These studies should make it possible to increase knowledge on the advantages and disadvantages of controlled access to cannabis. In particular, they will make it possible to assess and document, in a scientific framework, its effects on the health of users and on consumption habits, but also to measure its impact on the local illicit drug market as well as on the protection of young people. and on public safety.

Controlled products and risk awareness

As part of the pilot tests, consumers will be able to legally acquire various cannabis products. The proposed cannabis must meet high quality requirements and be organically grown. As supply chains are followed and tightly controlled from seed to product distribution, the black market will be bypassed. In addition to product information, participants will be made aware of the risks associated with consumption by point of sale staff who will be trained accordingly.

Strictly supervised pilot tests

Pilot tests will be rigorously supervised. Strict youth and health protection requirements as well as a total advertising ban will be applied. The quantity of cannabis that participants can buy per month will be limited, its resale prohibited, as will its consumption in public places. Only adults who already use cannabis will be able to participate in a study, minors will be excluded. The participants must, moreover, reside in the canton where the pilot test is set up. Finally, their state of health will be monitored throughout the study.

The validity of the article on pilot projects of the law on narcotic drugs is limited to ten years. Apart from the pilot tests, the general ban on non-medical cannabis remains in force throughout Switzerland. 


Address for sending questions

Federal Office of Public Health, Communication, + 41 58 462 95 05, media@bag.admin.ch

Source: https://www.bag.admin.ch/bag/fr/home/das-bag/aktuell/medienmitteilungen.msg-id-82917.html

Primary Sponsors


Karma Koala Podcast

Top Marijuana Blog